CorMedix (CRMD) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.81 million .
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Arrive AI and DXC Technology partner to bring delivery tech to factories
- Amneal gets FDA approval for lanreotide injection, launches immediately
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
